Primum non nocere. Quomo sapere? [Firstly, do no harm. How can we know this?] Drug-eluting stents versus surgery
Downloads
References
Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358(4):331-41.
de Lemos HP Jr, Atallah AN. Does the use of paclitaxel or ra- pamycin-eluting stent decrease further need for coronary-artery bypass grafting when compared with bare-metal stent? Sao Paulo Med J. 2007;125(4):242-5.
de Lemos HP Jr, Atallah AN, Gomes WJ. Drug-eluting stent in diabetes. Sao Paulo Med J. 2007;125(5):259-60.
Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356(10):989-97.
Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials compar- ing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356(10):1030-9.
Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28(22):2706-13.
Mauri L, Hsieh WH, Massaro JM, Ho KK, D’Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020-9.
Mauri L, O’Malley AJ, Popma JJ, et al. Comparison of thrombosis and restenosis risk from stent length of siroli- mus-eluting stents versus bare metal stents. Am J Cardiol. 2005;95(10):1140-5.
Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356(10):1009-19.
Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370(9591):937-48.
Vlaar PJ, Svilaas T, van der Horst IC, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet. 2008;371(9628):1915-20.
